Search

Your search keyword '"Diamond, M.P."' showing total 575 results
Start Over Author "Diamond, M.P."
575 results on '"Diamond, M.P."'

1. Ovarian Stimulation Strategies for Intrauterine Insemination in Couples with Unexplained Infertility - A Systematic Review and Individual Participant Data Meta-analysis

Author

WESSEL, J.A., primary, DANHOF, N.A., additional, VAN EEKELEN, R., additional, DIAMOND, M.P., additional, LEGRO, R.S., additional, PEERAER, K., additional, ERDEM, M., additional, DANKERT, T., additional, ECOCHARD, R., additional, MOL, B.W., additional, VAN WELY, M., additional, MOCHTAR, M.H., additional, and WANG, R., additional

Published
2022
Full Text
View/download PDF

2. Black women are more likely than white women to schedule a uterine-sparing treatment for leiomyomas

Author

Marsh, E.E., Spies, J.B., Vines, A.I., Diamond, M.P., Anchan, R.M., Wise, L.A., Jacoby, V.L., Venable, S., Zhang, S., Laughlin-Tommaso, S., Maxwell, G.L., Stewart, E.A., Myers, E.R., Wallace, K., Li, F., Nicholson, W.K., Thomas, L., and Wegienka, G.

Abstract

Background: To evaluate differences in the proportion of uterine fibroid (UF) treatments that are uterine-sparing between Black women and White women and identify factors that could explain disparities. Methods: Women at age 18-54 years who were enrolled from 10 clinical sites in the United States into the Comparing Options for Management: Patient-Centered Results for UFs (COMPARE-UF) treatment registry completed questionnaires before their UF procedure. UF symptoms and quality of life were assessed by questionnaires. Details on UF imaging and treatment (hysterectomy, myomectomy, or uterine artery embolization [UAE]) were collected from each patient's medical record. Random-effects logistic regression was used to assess the association between race and the odds of having a uterine-sparing procedure versus hysterectomy. Subgroup analyses compared each uterine-sparing procedure with hysterectomy. Results: In this cohort of 1141 White women and 1196 Black women, Black women tended to be younger (median 41.0 vs. 42.0 years) and report worse symptoms, pain, and function on every scale compared with White women. Black women were more likely to have had a prior UF treatment compared with White women (22.8% vs. 14.6%). White women had more hysterectomies (43.6% vs. 32.2%) and myomectomies (50.9% vs. 50.2%) versus Black women. Black women had more UAEs (15.1% vs. 4.7%) than White women. After adjusting for clinical site and other variables, Black women had greater odds than White women of having a myomectomy (odds ratio [OR] = 2.41, 95% confidence interval [CI] = 1.63-3.56) or a UAE versus hysterectomy (OR = 4.24, 95% CI = 2.41-7.46). Conclusion: In these participants, Black women were more likely to schedule a uterine-sparing UF treatment and a nonsurgical UF treatment than their White counterparts; this may not be true for all women. Longer comparative effectiveness studies are needed to inform women about the durability of UF treatments. Greater understanding of factors influencing treatment selection is needed as are studies that include women without access to tertiary care centers. Clinical Trial Registration: Clinicaltrials.gov, NCT02260752 (enrollment start: November 2015).

Published
2021
Full Text
View/download PDF

8. Session 27. Sterility: diagnosis and treatment

Author

Grillo, M., Kaya, S., Buck, S., Comhaire, F.H., Schoonjans, F., Farley, T., Rowe, P., van der Ven, H., Thieblod, A., Wagner, U., Schlebusch, H., Diedrich, K., Krebs, D., Eggert-Kruse, W., Rohr, G., Jochum, R., Adolph, M., Runnebaum, B., Marana, R., Lucisano, A., Muzii, L., Rizzi, M., Vitale, A.M., Dell'Acqua, S., Mancuso, S., Bianchi, G., de Candolle, G., Bischof, P., Campana, A., Diamond, M.P., Azziz, R., Cohen, S., Curole, D.N., Franklin, R.R., Haney, A.F., Malinak, L.R., Maxson, W.S., Patton, G.W., Rock, J.A., Rosenberg, S., Webster, B.W., Yuzpe, A.A., and Daya, S.

Published
2017

13. Adhesion prevention and reduction: current status and future recommendations of a multinational interdisciplinary consensus conference

Author

Diamond, M.P., Wexner, S.D., DiZereg, G.S., Korell, M., Zmora, O., Goor, H. van, and Kamar, M.

Subjects
Tissue engineering and pathology [NCMLS 3]
Abstract

Contains fulltext : 87950.pdf (Publisher’s version ) (Closed access) Adhesions can be found after virtually every abdominopelvic operation performed through standard laparotomy as well as by laparoscopic approaches. Adhesions can be completely asymptomatic or can cause significant morbidity and mortality including strangulation, obstruction, and necrosis of bowel loops and/or infertility and organ injury during repeat abdominal surgery. Perhaps because of the multifactorial nature of adhesion development, prevention has been very limited. Three anti-adhesion products are commercially available, none of which has been universally accepted as a panacea. Part of the obstacles with adhesion management is the lack of an objective clinically relevant classification to allow their study. Because a single band can cause a life-threatening bowel obstruction, whereas extensive dense intra-abdominal adhesions may be asymptomatic, neither the mere presence or absence of adhesions nor their extent if present is totally adequate endpoints. Adhesions are a major health care burden, and their reduction is a significant unmet need in surgical therapeutics facing all surgeons. Of all the parameters assessing adhesions currently available, the authors believe that adhesion incidence (presence or absence) is the most relevant endpoint with a direct clinical implication. The authors endorse the development of a validated, clinically relevant scale to assess intra-abdominal adhesions. Given the present limitation of objective assessment of adhesions and prediction of their clinical effect, the authors also advocate, when appropriate, the use of one of the Food and Drug Administration-approved adhesion barriers. Further research is required to develop safe and effective anti-adhesion methods as well as better assessment tools for their efficacy. 01 september 2010

Published
2010

19. Probability of pregnancy with mono versus multiple folliculogenesis among women with unexplained infertility who are undergoing ovulation with gonadotropins, clomiphene or letrozole

Author

Plowden, T.C., primary, Mumford, S.L., additional, Wild, R.A., additional, Cedars, M., additional, Steiner, A.Z., additional, Eisenberg, E., additional, Franasiak, J.M., additional, Diamond, M.P., additional, Santoro, N., additional, and Network, R.M., additional

Published
2017
Full Text
View/download PDF

38. Utility of sonohysterography for tubal patency assessment in the pregnancy in polycystic ovary syndrome II trial

Author

Christianson, M.S., primary, Legro, R., additional, Jin, S., additional, Eisenberg, E., additional, Diamond, M.P., additional, Hansen, K.R., additional, Vitek, W., additional, Styer, A.K., additional, Casson, P.R., additional, Coutifaris, C., additional, Christman, G.M., additional, Alvero, R., additional, Puscheck, E.E., additional, Christy, A., additional, Zhang, H., additional, Polotsky, A.J., additional, and Santoro, N., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results